Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile

Metabolism evaluation of the anticancer candidate AC04 by biomimetic oxidative model and rat liver microsomes

(2011) Maiara Cássia Pigatto et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

DEVELOPMENT AND VALIDATION OF AN LC-MS/MS METHOD FOR THE PRE-CLINICAL PHARMACOKINETIC INVESTIGATION OF THE ANTICANCER CANDIDATE AC04 IN RODENTS

(2011) Flávia De Toni Uchôa et al.   JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES

Pre-clinical pharmacokinetics evaluation of an anticonvulsant candidate benzaldehyde semicarbazone free and included in β-cyclodextrin

(2010) Moacir Kaiser et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Glicoproteína-P, resistência a múltiplas drogas (MDR) e relação estrutura-atividade de moduladores

(2010) Paula C. Huber et al.   QUIMICA NOVA

Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives

(2009) Sham M. Sondhi et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and antitumor activity of novel amsacrine analogs: The critical role of the acridine moiety in determining their biological activity

(2008) Adriana Chilin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II

(2008) Lisa M. Oppegard et al.   EUROPEAN JOURNAL OF PHARMACOLOGY